CVS HEALTH CORPORATION - CVS STOCK NEWS

CVS Health Corporation (CVS) has announced early results of its cash tender offers for up to $6 billion in senior notes due in 2023 and 2025. The offers include 4% and 3.7% senior notes due 2023, and 4.1% and 3.875% senior notes due 2025. As of the early tender date on August 25, 2020, significant amounts have been tendered, with notable participation exceeding the maximum amounts set for each note series. CVS plans to accept valid tenders on a prorated basis due to high demand, with settlement expected on August 27, 2020. The total consideration includes an early tender payment of $30 per $1,000.

CVS Health emphasizes the importance of vaccinations amid COVID-19, urging the public to get flu shots this season. A survey revealed that 66% of U.S. consumers intend to receive a flu shot, up from 34% in January 2020, with many opting for earlier immunizations. Flu shots are available at nearly 10,000 CVS Pharmacy and 100 MinuteClinic locations across the U.S. To ensure safety, CVS has implemented health protocols during vaccination. Customers can receive a $5 coupon for a $20 purchase when they get a flu shot, valid until October 31.

CVS Health is expanding its COVID-19 testing capacity by launching 77 additional drive-thru test sites in Florida, bringing the total to 298 locations in the state effective August 21, 2020. This initiative is part of CVS's broader effort to enhance access to testing, with over 1,900 testing locations nationwide since May. Patients will have no out-of-pocket costs as tests are covered by insurance or funded through a program for the uninsured. CVS aims to provide test results within 2-5 days, improving turnaround times through partnerships with independent labs.

Aetna, part of CVS Health, is launching the Attain Games, a virtual wellness event from August 23 to August 29, 2020. The event features daily challenges tailored by U.S. athletes, including workouts and mindfulness activities, encouraging users to achieve health goals at home. Participants earn points, vying for gold, silver, and bronze statuses. Since its 2019 launch, the Attain app has seen users burn 6 billion calories and redeem $1.8 million in rewards. The program emphasizes user privacy, offering voluntary participation with secure data handling.

CVS Health announced the hiring of approximately 300 new jobs in Arizona as part of its response to the expected surge in demand for influenza vaccinations and ongoing COVID-19 testing. These seasonal roles, including part-time and full-time licensed pharmacy technicians, aim to strengthen healthcare access in underserved areas. The initiative comes amid high unemployment rates due to the pandemic. Candidates must have a technician in training license. This expansion highlights CVS's commitment to public health and job creation in the state.

CVS Health Corporation (NYSE: CVS) has launched cash tender offers totaling $6 billion for its Senior Notes due in 2023 and 2025. The offers aim to refinance existing debt with up to $3 billion available for each group of notes. Key dates include the Early Tender Date on August 25, 2020, and the Expiration Date on September 9, 2020. These strategic moves are designed to lower CVS Health's overall indebtedness and enhance financial flexibility.

CVS Health has launched a free rapid COVID-19 testing site in Glendale, Arizona, effective August 7, 2020. The site, located at 6030 North 43rd Ave., aims to enhance community access to testing, particularly in underserved areas. Testing is available by appointment, requiring pre-registration. Results will be provided on-the-spot, and no personal vehicle is needed. CVS collaborates with local organizations, including Valle del Sol and Mercy Care, to facilitate awareness and support for those tested. The initiative reflects CVS's commitment to addressing health disparities and expanding testing across the country.

CVS Health reports a 3.0% increase in total revenues for Q2 2020, reaching $65.3 billion, and a 40.5% rise in GAAP operating income to $4.7 billion. Adjusted EPS rose to $2.64, reflecting a strong response to COVID-19. The company raised its full-year GAAP diluted EPS guidance to $5.59-$5.72 and adjusted EPS to $7.14-$7.27. Significant operational efforts include over 1,800 COVID-19 test sites and the launch of Return Ready, a testing solution for businesses. Despite challenges in Retail due to pandemic-related restrictions, overall performance remained solid.